Key facts
- Medicare will cover GLP-1 receptor agonist drugs for weight loss for eligible beneficiaries.
- Coverage begins July 1.
- The drugs will be available for approximately $50 per month for eligible individuals.
- This policy shift aims to increase access to weight management therapies for older adults.
Medicare has announced it will begin covering GLP-1 receptor agonist drugs for weight loss, a significant policy shift that will expand access for eligible seniors starting July 1. The move aims to address the growing prevalence of obesity among older adults and its associated health complications, such as diabetes and heart disease.
Under the new policy, eligible Medicare beneficiaries will have access to these medications with a substantially reduced out-of-pocket cost, potentially around $50 per month. This contrasts with current costs that can range up to $1000 monthly, a barrier that has historically limited treatment initiation and adherence for many.